Emergent Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Emergent Biosolutions
EBS Stock  USD 5.79  0.08  1.40%   
Emergent Biosolutions financial statements provide useful quarterly and yearly information to potential Emergent Biosolutions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Emergent Biosolutions financial statements helps investors assess Emergent Biosolutions' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Emergent Biosolutions' valuation are summarized below:
Gross Profit
290.1 M
Profit Margin
(0.19)
Market Capitalization
540.2 M
Enterprise Value Revenue
0.8627
Revenue
1.1 B
There are over one hundred nineteen available fundamental signals for Emergent Biosolutions, which can be analyzed over time and compared to other ratios. All traders should verify Emergent Biosolutions' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1.8 B in 2025. Enterprise Value is likely to gain to about 1.7 B in 2025

Emergent Biosolutions Total Revenue

583.91 Million

Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 114.2 M, Interest Expense of 74.5 M or Total Revenue of 583.9 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.018 or PTB Ratio of 1.0. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
  
Check out the analysis of Emergent Biosolutions Correlation against competitors.
For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Emergent Biosolutions Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.2 B1.4 B1.5 B
Slightly volatile
Short and Long Term Debt Total383.1 M663.7 M484.4 M
Slightly volatile
Other Current Liabilities68.6 M101.5 M82.4 M
Slightly volatile
Total Current Liabilities228 M162.4 M276.2 M
Slightly volatile
Property Plant And Equipment Net371.4 M270.6 M446.5 M
Slightly volatile
Accounts Payable61.9 M60.9 M73.6 M
Slightly volatile
Cash94.5 M99.5 M246.2 M
Slightly volatile
Non Current Assets Total802.4 M791 M1 B
Slightly volatile
Non Currrent Assets Other18 M18.9 M51.3 M
Slightly volatile
Cash And Short Term Investments94.5 M99.5 M246.3 M
Pretty Stable
Net Receivables137.7 M154.5 M166 M
Slightly volatile
Good Will142.3 M250.9 M145.5 M
Slightly volatile
Common Stock Shares Outstanding42.1 M53 M45.5 M
Slightly volatile
Liabilities And Stockholders Equity1.2 B1.4 B1.5 B
Slightly volatile
Non Current Liabilities Total414.1 M744.5 M528.5 M
Slightly volatile
Inventory327.3 M311.7 M194.8 M
Slightly volatile
Other Current Assets26.3 M33 M32.1 M
Slightly volatile
Total Liabilities549.1 M906.9 M712.7 M
Slightly volatile
Total Current Assets535.9 M598.7 M672.1 M
Slightly volatile
Short Term Debt499.5 M475.8 M165.6 M
Slightly volatile
Intangible Assets404.7 M501.5 M390 M
Slightly volatile
Common Stock63.6 K115 K72.3 K
Slightly volatile
Other Liabilities66.7 M104 M82.5 M
Slightly volatile
Current Deferred Revenue28.1 M30.4 M34.5 M
Slightly volatile
Long Term Debt696.9 M663.7 M402.5 M
Slightly volatile
Common Stock Total Equity120.8 K115 K70.8 K
Slightly volatile
Property Plant And Equipment Gross396.8 M667.7 M459 M
Slightly volatile
Property Plant Equipment987.3 M940.2 M514.4 M
Slightly volatile
Net Tangible Assets1 B1.6 B927.9 M
Slightly volatile
Long Term Debt Total520.5 M515.8 M386.4 M
Slightly volatile
Capital Surpluse663.5 M1 B564.5 M
Slightly volatile
Non Current Liabilities Other72.7 M39.1 M54.8 M
Slightly volatile
Short and Long Term Debt499.5 M475.8 M248.1 M
Slightly volatile
Deferred Long Term Asset Charges9 M10.2 M11.1 M
Slightly volatile
Cash And Equivalents403.8 M739 M374 M
Slightly volatile
Net Invested Capital2 B1.1 B1.5 B
Slightly volatile
Capital Stock80 K90 K98.1 K
Slightly volatile

Emergent Biosolutions Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization114.2 M108.8 M68.2 M
Slightly volatile
Total Revenue583.9 M1 B746.3 M
Slightly volatile
Other Operating Expenses627.4 M1.2 B795.8 M
Slightly volatile
Research Development126 M70.7 M150.4 M
Very volatile
Cost Of Revenue0.951.0286.3 M
Slightly volatile
Total Operating Expenses1.2 B1.2 B544.3 M
Slightly volatile
Income Tax Expense25.5 M47.7 M30.8 M
Slightly volatile
Selling General Administrative177.9 M308 M197.7 M
Slightly volatile
Tax Provision48.8 M47.7 M44.6 M
Very volatile
Interest Income22 M42.9 M18.3 M
Slightly volatile
Reconciled Depreciation115.1 M108.8 M78.1 M
Slightly volatile

Emergent Biosolutions Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation19.3 M18 M21.6 M
Slightly volatile
Begin Period Cash Flow106.1 M111.7 M251.5 M
Slightly volatile
Depreciation114.2 M108.8 M68.3 M
Slightly volatile
Capital Expenditures21.8 M22.9 M69.4 M
Slightly volatile
End Period Cash Flow100.3 M105.6 M247.1 M
Slightly volatile
Change To Netincome44.4 M48.1 M38.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.470.49992.207
Slightly volatile
Dividend Yield0.0180.02020.0221
Slightly volatile
Days Sales Outstanding52.8555.6359191
Slightly volatile
Stock Based Compensation To Revenue0.01690.01780.0864
Slightly volatile
Capex To Depreciation0.20.21051.6711
Slightly volatile
EV To Sales1.01.05652.4206
Slightly volatile
Days Of Inventory On Hand119.5 B113.8 B14.6 B
Slightly volatile
Sales General And Administrative To Revenue0.310.30.2746
Very volatile
Research And Ddevelopement To Revenue0.06630.06980.4771
Slightly volatile
Capex To Revenue0.02150.02260.405
Slightly volatile
Cash Per Share3.71.87745.5459
Pretty Stable
Payout Ratio0.270.310.3356
Slightly volatile
Days Payables Outstanding23.3 B22.2 B2.8 B
Slightly volatile
Intangibles To Total Assets0.340.36092.5186
Slightly volatile
Current Ratio2.613.68663.5376
Slightly volatile
Receivables Turnover7.176.56054.7853
Slightly volatile
Capex Per Share0.410.43212.232
Slightly volatile
Revenue Per Share9.7819.124515.6021
Slightly volatile
Interest Debt Per Share14.5613.862310.6135
Slightly volatile
Debt To Assets0.320.47760.3407
Very volatile
Graham Number49.9547.5731.4355
Slightly volatile
Operating Cycle119.5 B113.8 B14.6 B
Slightly volatile
Days Of Payables Outstanding23.3 B22.2 B2.8 B
Slightly volatile
Dividend Payout Ratio0.270.310.3356
Slightly volatile
Ebt Per Ebit1.131.31461.0342
Very volatile
Long Term Debt To Capitalization0.610.57890.3112
Slightly volatile
Total Debt To Capitalization0.550.57891.7202
Slightly volatile
Quick Ratio2.881.76722.8285
Slightly volatile
Net Income Per E B T1.41.33380.8418
Slightly volatile
Cash Ratio0.580.61271.5237
Slightly volatile
Days Of Inventory Outstanding119.5 B113.8 B14.6 B
Slightly volatile
Days Of Sales Outstanding52.8555.6359191
Slightly volatile
Fixed Asset Turnover3.933.74581.8324
Slightly volatile
Debt Ratio0.320.47760.3407
Very volatile
Price Sales Ratio0.470.49992.207
Slightly volatile
Asset Turnover0.860.72940.611
Pretty Stable

Emergent Biosolutions Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B1.7 B1.5 B
Slightly volatile
Enterprise Value1.7 B1.6 B1.3 B
Slightly volatile

Emergent Fundamental Market Drivers

Forward Price Earnings17.8571
Cash And Short Term Investments99.5 M

Emergent Upcoming Events

26th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Emergent Biosolutions Financial Statements

Emergent Biosolutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue30.4 M28.1 M
Total Revenue1 B583.9 M
Cost Of Revenue 1.00  0.95 
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.31 
Research And Ddevelopement To Revenue 0.07  0.07 
Capex To Revenue 0.02  0.02 
Revenue Per Share 19.12  9.78 
Ebit Per Revenue(0.11)(0.10)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY